• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远志三通过泛素蛋白酶体系统抑制 Aβ 诱导的阿尔茨海默病大鼠模型中的 tau 蛋白聚集。

Yuan‑zhi‑san inhibits tau protein aggregation in an Aβ‑induced Alzheimer's disease rat model via the ubiquitin‑proteasome system.

机构信息

Geriatric Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China.

Department of Chinese Internal Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China.

出版信息

Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11918. Epub 2021 Feb 19.

DOI:10.3892/mmr.2021.11918
PMID:33604685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893680/
Abstract

Yuan‑zhi‑san (YZS) is a classic type of Traditional Chinese Medicine, which has been reported to aid in the treatment of Alzheimer's disease (AD). The present study aimed to investigate the effects of YZS on tau protein aggregation, a hallmark of AD pathology, and its possible mechanisms. The results demonstrated that YZS improved learning and memory abilities, and decreased the severity of AD pathology in β‑amyloid (Aβ)‑induced AD rats. Moreover, YZS administration inhibited the hyperphosphorylation of tau protein at Ser199 and Thr231 sites. Several vital enzymes in the ubiquitin‑proteasome system (UPS), including ubiquitin‑activating enzyme E1a/b, ubiquitin‑conjugating enzyme E2a, carboxyl terminus of Hsc70‑interacting protein, ubiquitin C‑236 terminal hydrolase L1 and 26S proteasome, were all significantly downregulated in AD rats, which indicated an impaired enzymatic cascade in the UPS. In addition, it was identified that YZS treatment partly increased the expression levels of these enzymes in the brains of AD rats. In conclusion, the present results suggested that YZS could effectively suppress the hyperphosphorylation of tau proteins, which may be partially associated with its beneficial role in restoring functionality of the UPS.

摘要

元智散(YZS)是一种经典的中药,据报道可辅助治疗阿尔茨海默病(AD)。本研究旨在探讨 YZS 对 AD 病理标志性蛋白tau 蛋白聚集的影响及其可能的机制。结果表明,YZS 可改善学习记忆能力,并降低β-淀粉样蛋白(Aβ)诱导的 AD 大鼠 AD 病理的严重程度。此外,YZS 给药可抑制 tau 蛋白 Ser199 和 Thr231 位点的过度磷酸化。泛素-蛋白酶体系统(UPS)中的几种重要酶,包括泛素激活酶 E1a/b、泛素结合酶 E2a、Hsc70 相互作用蛋白羧基末端、泛素 C-236 末端水解酶 L1 和 26S 蛋白酶体,在 AD 大鼠中均显著下调,表明 UPS 中的酶级联反应受损。此外,研究还发现 YZS 治疗可部分增加 AD 大鼠大脑中这些酶的表达水平。综上所述,本研究结果表明,YZS 可有效抑制 tau 蛋白的过度磷酸化,这可能与其恢复 UPS 功能的有益作用部分相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/7f15e522803e/mmr-23-04-11918-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/fec79d284c6b/mmr-23-04-11918-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/f0064270641c/mmr-23-04-11918-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/9b6d00db2815/mmr-23-04-11918-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/a22a76302abd/mmr-23-04-11918-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/7f15e522803e/mmr-23-04-11918-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/fec79d284c6b/mmr-23-04-11918-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/f0064270641c/mmr-23-04-11918-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/9b6d00db2815/mmr-23-04-11918-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/a22a76302abd/mmr-23-04-11918-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ad/7893680/7f15e522803e/mmr-23-04-11918-g04.jpg

相似文献

1
Yuan‑zhi‑san inhibits tau protein aggregation in an Aβ‑induced Alzheimer's disease rat model via the ubiquitin‑proteasome system.远志三通过泛素蛋白酶体系统抑制 Aβ 诱导的阿尔茨海默病大鼠模型中的 tau 蛋白聚集。
Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11918. Epub 2021 Feb 19.
2
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.紫草素调节 Tau 衍生的 VQIVYK 纤维形成,并改善动物模型中的阿尔茨海默病样症状。
Cell Mol Life Sci. 2020 Jul;77(14):2795-2813. doi: 10.1007/s00018-019-03312-0. Epub 2019 Sep 27.
3
Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.复智散通过减少海马体中β淀粉样蛋白生成和tau蛋白过度磷酸化改善衰老SAMP8小鼠的记忆缺陷。
Neurochem Res. 2016 Nov;41(11):3074-3082. doi: 10.1007/s11064-016-2028-4. Epub 2016 Aug 12.
4
Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.羌活提取物(NRE)通过减轻淀粉样蛋白-β、tau 和神经炎症病理学来挽救 APP/PS1 阿尔茨海默病小鼠的认知缺陷。
J Ethnopharmacol. 2020 Mar 1;249:112433. doi: 10.1016/j.jep.2019.112433. Epub 2019 Nov 27.
5
Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.人淀粉样β肽和 tau 共表达可损害行为并导致秀丽隐杆线虫中特定基因表达的改变。
Neurobiol Dis. 2018 Jan;109(Pt A):88-101. doi: 10.1016/j.nbd.2017.10.003. Epub 2017 Oct 2.
6
Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer's disease using patient iPSC-derived neurons.利用患者诱导多能干细胞衍生神经元评估叉叶对叶花(Graptopetalum paraguayense)治疗阿尔茨海默病的潜力。
Sci Rep. 2019 Dec 17;9(1):19301. doi: 10.1038/s41598-019-55614-9.
7
SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.K340位点的小泛素样修饰蛋白化通过失调tau蛋白的磷酸化和泛素化来抑制其降解。
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16586-91. doi: 10.1073/pnas.1417548111. Epub 2014 Nov 5.
8
Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.辣木减轻同型半胱氨酸诱导的阿尔茨海默病样病变和认知障碍。
J Alzheimers Dis. 2018;63(3):1141-1159. doi: 10.3233/JAD-180091.
9
Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.甲苯胺蓝 O 修饰阿尔茨海默病转基因小鼠模型海马淀粉样蛋白病理。
Biochimie. 2018 Mar;146:105-112. doi: 10.1016/j.biochi.2017.12.004. Epub 2017 Dec 14.
10
The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.新型组蛋白去乙酰化酶 6 抑制剂 MPT0G211 可改善阿尔茨海默病模型中的 Tau 磷酸化和认知缺陷。
Cell Death Dis. 2018 May 29;9(6):655. doi: 10.1038/s41419-018-0688-5.

引用本文的文献

1
Network pharmacology implicates traditional Chinese medicine in regulating systemic homeostasis to benefit Alzheimer's disease.网络药理学表明中药在调节全身稳态以改善阿尔茨海默病方面具有重要作用。
Tzu Chi Med J. 2023 Feb 13;35(2):120-130. doi: 10.4103/tcmj.tcmj_125_22. eCollection 2023 Apr-Jun.
2
Yuan-Zhi decoction in the treatment of Alzheimer's disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation.远志汤治疗阿尔茨海默病:基于化学图谱分析、网络药理学、分子对接和实验评估的综合方法
Front Pharmacol. 2022 Aug 24;13:893244. doi: 10.3389/fphar.2022.893244. eCollection 2022.
3

本文引用的文献

1
Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease.探索靶向泛素-蛋白酶体系统治疗阿尔茨海默病的前景。
Neurotox Res. 2020 Jun;38(1):8-17. doi: 10.1007/s12640-020-00185-1. Epub 2020 Mar 9.
2
An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease.胆碱酯酶抑制剂治疗阿尔茨海默病的作用和安全性更新。
Expert Opin Drug Saf. 2020 Feb;19(2):147-157. doi: 10.1080/14740338.2020.1721456. Epub 2020 Jan 28.
3
[β Amyloid Hypothesis in Alzheimer's Disease:Pathogenesis,Prevention,and Management].
Active Compounds and Targets of Yuanzhi Powder in Treating Alzheimer's Disease and Its Relationship with Immune Infiltration Based on HPLC Fingerprint and Network Pharmacology.
基于高效液相色谱指纹图谱和网络药理学的远志散治疗阿尔茨海默病的活性成分、靶点及其与免疫浸润的关系
Evid Based Complement Alternat Med. 2022 Jul 15;2022:3389180. doi: 10.1155/2022/3389180. eCollection 2022.
4
Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction.人参皂苷Rb1通过干扰β-连环蛋白/TCF4相互作用减轻胃癌前病变。
Front Pharmacol. 2021 Sep 14;12:682713. doi: 10.3389/fphar.2021.682713. eCollection 2021.
[阿尔茨海默病中的β淀粉样蛋白假说:发病机制、预防与管理]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Oct 30;41(5):702-708. doi: 10.3881/j.issn.1000-503X.10875.
4
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.冰山一角:评估阿尔茨海默病和相关痴呆症的全球社会经济成本及其对利益相关者的战略意义。
J Alzheimers Dis. 2019;70(2):323-341. doi: 10.3233/JAD-190426.
5
Ginsenoside Rb1 improves learning and memory ability through its anti-inflammatory effect in Aβ induced Alzheimer's disease of rats.人参皂苷Rb1通过其抗炎作用改善Aβ诱导的大鼠阿尔茨海默病的学习和记忆能力。
Am J Transl Res. 2019 May 15;11(5):2955-2968. eCollection 2019.
6
The cost of Alzheimer's disease in China and re-estimation of costs worldwide.中国阿尔茨海默病的成本及对全球成本的再估计。
Alzheimers Dement. 2018 Apr;14(4):483-491. doi: 10.1016/j.jalz.2017.12.006. Epub 2018 Feb 9.
7
[Memantine: from the original brand to generics].[美金刚:从原研药到仿制药]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):136-143. doi: 10.17116/jnevro2017117101136-143.
8
Baicalin and ginsenoside Rb1 promote the proliferation and differentiation of neural stem cells in Alzheimer's disease model rats.黄芩苷和人参皂苷Rb1促进阿尔茨海默病模型大鼠神经干细胞的增殖和分化。
Brain Res. 2018 Jan 1;1678:187-194. doi: 10.1016/j.brainres.2017.10.003. Epub 2017 Oct 14.
9
Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.阿尔茨海默病大脑中 Aβx - 40 的神经原纤维缠结
J Alzheimers Dis. 2017;58(3):661-667. doi: 10.3233/JAD-170163.
10
Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies.阿尔茨海默病中的tau蛋白:机制与治疗策略
Curr Alzheimer Res. 2018;15(3):283-300. doi: 10.2174/1567205014666170417111859.